로딩 중…
지수 로딩 중…
Bio Plus Co., Ltd
099430· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,345-2.03%
2026-06-19
Price Chart
Bio Plus Co., Ltd-40.56%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 267.83B KRW |
| Revenue | 94.42B KRW |
| Net Income | 2.31B KRW |
| Total Assets | 297.50B KRW |
| Net Assets | 199.02B KRW |
| Employees | 155 |
| Value | |
| P/E | 116.04x |
| P/B | 1.35x |
| PEG | 29.32x |
| P/S | 2.84x |
| FCF Yield | -11.89% |
| Profitability | |
| ROE | 1.16% |
| ROA | 0.78% |
| Op. Margin | -0.52% |
| Revenue Growth | 15.35% |
| Earnings Growth | 3.96% |
| Financial Health | |
| Debt Ratio | 149.48% |
| Total Debt | 79.60B KRW |
| FCF | -31.84B KRW |
| Cash | 23.02B KRW |
| Current Ratio | 0.94x |
| Dividend | |
| Div. Yield | 1.58% |
| Div. Growth | 40.00% |
| Performance | |
| 1Y Return | -40.56% |
| 1M Return | -15.14% |
| From 52W High | -47.96% |
| 1Y MDD | -45.60% |
| Trading | |
| Volume | 538,242 shares |
| Foreign Own. | 3.04% |
| Per Share | |
| EPS | 228 KRW |
| BPS | 2,885 KRW |
Company Info
Established in 2003 and rebranded in 2013, the company expanded its business in 2025 by establishing BioPlus USA Inc. and acquiring equity. It primarily focuses on the research, development, manufacturing, and sales of hyaluronic acid-based medical devices and Bio Cosmetic products, while also concentrating on developing next-generation botulinum toxin and obesity treatments. Employing a technology-driven strategy, the company exports to over 70 overseas countries and is accelerating its global market entry by establishing an overseas subsidiary and local production facilities in China. BioPlus was established in 2003 and is headquartered in Gyeonggi-do, Seongnam-si.